We chose to investigate CD5 antigen as CD5 is highly expressed in the majority of T-ALL and T cell lymphoma [58, 59], but also in a fraction of B cell tumor, such as CLL and MCL [60, 61]. This evidence concerns the gene CD5 and B-cell chronic lymphocytic leukemia.